FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2465253403> ?p ?o ?g. }

• W2465253403 abstract "To compare definitive radiochemotherapy with weekly administration of 30–40 mg/m2 of cisplatin to 100 mg/m2 of cisplatin on days 1, 22 and 43 for outcomes and toxicity in patients with squamous cell carcinoma of the head-and-neck. Seventy-five patients receiving radiochemotherapy with weekly cisplatin (30–40 mg/m2) were compared to 58 patients receiving radiochemotherapy with 100 mg/m2 cisplatin on days 1, 22 and 43. Radiochemotherapy regimen plus seven characteristics (age, gender, performance score, tumor site, T-/N-category, histologic grading) were evaluated for locoregional control (LRC), metastases-free survival (MFS) and overall survival (OS). Radiochemotherapy groups were compared for toxicity. On multivariate analysis, improved LRC was associated with cisplatin 100 mg/m2 (hazard ratio [HR] 1.57; p = 0.008) and female gender (HR 4.37; p = 0.003). Radiochemotherapy regimen was not significantly associated with MFS on univariate analysis (p = 0.66). On multivariate analysis, better MFS was associated with ECOG performance score 0–1 (HR 5.63; p < 0.001) and histological grade 1–2 (HR 1.81; p = 0.002). On multivariate analysis, improved OS was associated with cisplatin 100 mg/m2 (HR 1.33; p = 0.023), ECOG performance score 0–1 (HR 2.15; p = 0.029) and female gender (HR 1.98; p = 0.026). Cisplatin 100 mg/m2 was associated with higher rates of grade ≥3 hematotoxicity (p = 0.004), grade ≥2 renal failure (p = 0.004) and pneumonia/sepsis (p = 0.033). Radiochemotherapy with 100 mg/m2 of cisplatin every 3 weeks resulted in better LRC and OS than weekly doses of 30–40 mg/m2. Given the limitations of a retrospective study, 100 mg/m2 of cisplatin appears preferable. Since this regimen was associated with considerable acute toxicity, patients require close monitoring." @default.
• W2465253403 created "2016-07-22" @default.
• W2465253403 creator A5039322947 @default.
• W2465253403 creator A5040830331 @default.
• W2465253403 creator A5041640980 @default.
• W2465253403 creator A5057206849 @default.
• W2465253403 creator A5062848479 @default.
• W2465253403 creator A5065650315 @default.
• W2465253403 creator A5077237165 @default.
• W2465253403 date "2016-07-08" @default.
• W2465253403 modified "2023-10-11" @default.
• W2465253403 title "Comparison of weekly administration of cisplatin versus three courses of cisplatin 100 mg/m2 for definitive radiochemotherapy of locally advanced head-and-neck cancers" @default.
• W2465253403 cites W1784479792 @default.
• W2465253403 cites W1975369766 @default.
• W2465253403 cites W2004832292 @default.
• W2465253403 cites W2036005555 @default.
• W2465253403 cites W2062253457 @default.
• W2465253403 cites W2066334626 @default.
• W2465253403 cites W2088908474 @default.
• W2465253403 cites W2089257078 @default.
• W2465253403 cites W2100961085 @default.
• W2465253403 cites W2103717352 @default.
• W2465253403 cites W2113541736 @default.
• W2465253403 cites W2120068217 @default.
• W2465253403 cites W2138453480 @default.
• W2465253403 cites W2145078756 @default.
• W2465253403 cites W2147021586 @default.
• W2465253403 cites W2157627057 @default.
• W2465253403 cites W2172200669 @default.
• W2465253403 cites W2173840069 @default.
• W2465253403 cites W4293241248 @default.
• W2465253403 doi "https://doi.org/10.1186/s12885-016-2478-8" @default.
• W2465253403 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4938984" @default.
• W2465253403 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27391309" @default.
• W2465253403 hasPublicationYear "2016" @default.
• W2465253403 type Work @default.
• W2465253403 sameAs 2465253403 @default.
• W2465253403 citedByCount "20" @default.
• W2465253403 countsByYear W24652534032016 @default.
• W2465253403 countsByYear W24652534032017 @default.
• W2465253403 countsByYear W24652534032018 @default.
• W2465253403 countsByYear W24652534032019 @default.
• W2465253403 countsByYear W24652534032020 @default.
• W2465253403 countsByYear W24652534032021 @default.
• W2465253403 countsByYear W24652534032022 @default.
• W2465253403 countsByYear W24652534032023 @default.
• W2465253403 crossrefType "journal-article" @default.
• W2465253403 hasAuthorship W2465253403A5039322947 @default.
• W2465253403 hasAuthorship W2465253403A5040830331 @default.
• W2465253403 hasAuthorship W2465253403A5041640980 @default.
• W2465253403 hasAuthorship W2465253403A5057206849 @default.
• W2465253403 hasAuthorship W2465253403A5062848479 @default.
• W2465253403 hasAuthorship W2465253403A5065650315 @default.
• W2465253403 hasAuthorship W2465253403A5077237165 @default.
• W2465253403 hasBestOaLocation W24652534031 @default.
• W2465253403 hasConcept C126322002 @default.
• W2465253403 hasConcept C126894567 @default.
• W2465253403 hasConcept C143998085 @default.
• W2465253403 hasConcept C144301174 @default.
• W2465253403 hasConcept C207103383 @default.
• W2465253403 hasConcept C2776530083 @default.
• W2465253403 hasConcept C2776694085 @default.
• W2465253403 hasConcept C2776833033 @default.
• W2465253403 hasConcept C2778239845 @default.
• W2465253403 hasConcept C2778424827 @default.
• W2465253403 hasConcept C2781413609 @default.
• W2465253403 hasConcept C38180746 @default.
• W2465253403 hasConcept C44249647 @default.
• W2465253403 hasConcept C509974204 @default.
• W2465253403 hasConcept C71924100 @default.
• W2465253403 hasConcept C90924648 @default.
• W2465253403 hasConceptScore W2465253403C126322002 @default.
• W2465253403 hasConceptScore W2465253403C126894567 @default.
• W2465253403 hasConceptScore W2465253403C143998085 @default.
• W2465253403 hasConceptScore W2465253403C144301174 @default.
• W2465253403 hasConceptScore W2465253403C207103383 @default.
• W2465253403 hasConceptScore W2465253403C2776530083 @default.
• W2465253403 hasConceptScore W2465253403C2776694085 @default.
• W2465253403 hasConceptScore W2465253403C2776833033 @default.
• W2465253403 hasConceptScore W2465253403C2778239845 @default.
• W2465253403 hasConceptScore W2465253403C2778424827 @default.
• W2465253403 hasConceptScore W2465253403C2781413609 @default.
• W2465253403 hasConceptScore W2465253403C38180746 @default.
• W2465253403 hasConceptScore W2465253403C44249647 @default.
• W2465253403 hasConceptScore W2465253403C509974204 @default.
• W2465253403 hasConceptScore W2465253403C71924100 @default.
• W2465253403 hasConceptScore W2465253403C90924648 @default.
• W2465253403 hasIssue "1" @default.
• W2465253403 hasLocation W24652534031 @default.
• W2465253403 hasLocation W24652534032 @default.
• W2465253403 hasLocation W24652534033 @default.
• W2465253403 hasLocation W24652534034 @default.
• W2465253403 hasOpenAccess W2465253403 @default.
• W2465253403 hasPrimaryLocation W24652534031 @default.
• W2465253403 hasRelatedWork W2031206533 @default.
• W2465253403 hasRelatedWork W2110125130 @default.
• W2465253403 hasRelatedWork W2164312952 @default.
• W2465253403 hasRelatedWork W2313027913 @default.
• W2465253403 hasRelatedWork W2375386244 @default.
• W2465253403 hasRelatedWork W2418948479 @default.

• next